Evidence map›Paper›PMID 42523853›Full record

ArticleNordisk alkohol- & narkotikatidskrift : NAT2026

Medical Use and Misuse of Addictive Prescription Drugs and Mental Health Among Adolescents in Estonia.

Liina Veskimäe, Sigrid Vorobjov, Inge Ringmets, Kersti Pärna

Abstract read
In one paragraph

Article in Nordisk alkohol- & narkotikatidskrift : NAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Changing Worlds, Changing Drug Markets.Nordisk alkohol- & narkotikatidskrift : NAT · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liina VeskimäeInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID https://orcid.org/0009-0002-3023-8741
Sigrid VorobjovInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Inge RingmetsInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Kersti PärnaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID https://orcid.org/0000-0001-7677-9493

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: This study aimed to describe the prevalence and characteristics (sources, motivations, perceived health risks, accessibility) of medical use and misuse of addictive prescription drugs (APDs), and the prevalence of poor mental wellbeing and self-harm among adolescents in Estonia. In addition, this study examined associations between APD use status (non-use, medical use, misuse) and mental health indicators (mental wellbeing, self-harm). Methods: Data came from the nationally representative 2024 European School Survey Project on Alcohol and Other Drugs (ESPAD) survey of 15-16-year-olds in Estonia ( Results: Overall, 27.8% of adolescents reported APD medical use and 18.3% misuse, with higher prevalence among girls. Sedatives and sleeping pills were the most commonly medically used and misused APDs. Most misused APDs were obtained from home, and self-treatment motives predominated. Poor mental wellbeing (44.4%) and self-harm (17.6%) were most prevalent among misusers. APD misuse (. non-use) was associated with poor mental wellbeing, self-harm and female gender; misuse (vs. medical use) with self-harm; and APD medical use (vs. non-use) with self-harm and female gender. The strongest association was found between APD misuse (vs. non-use) and self-harm (adjusted odds ratio = 2.78). Conclusions: APD medical use and misuse are common among Estonian adolescents. APD misuse co-occurred with poor mental wellbeing and self-harm, highlighting the importance of integrating APD misuse prevention into broader adolescent mental health and substance use strategies.

Indexed as

adolescentsESPADEstoniamedical usemental healthmisuseprescription drugsself-harm

Identifiers

PMID42523853
PMCPMC13407665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.